AbCellera Biologics Investors

16 investors on Angel Roster list AbCellera Biologics in their portfolio. Most are private equity firms and venture capital firms, the most common stage is Series A and the largest groups are based in the United States, Israel and China.

Investors are matched on the company name in their portfolio, so companies that share the name AbCellera Biologics can appear together.

Investors listed
16
With verified email
63%
Most common stage
Series A
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 16 AbCellera Biologics investors

The most complete profiles first. Showing 16 of 16.

  • David BonitaVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 93 more

    Verified email available

  • Fabian HansenVerified

    Venture Capital, Founder, Private Equity Firm · United States

    Series BSeries AHealth CareDeepTechBiotechnologyConsumer Health

    Portfolio: Cleerly, Opontia, Alaan, Bamba and 13 more

    Verified email available

  • Geoffrey HsuVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Verified email available

  • Michael SolanaVerified

    Venture Capital, Investor · United States

    Series BHealth CareWellnessHR TechCryptocurrency

    Portfolio: IRL, Affirm, Motherly, Forward and 82 more

    Verified email available

  • Delian AsparouhovVerified

    Venture Capital, Private Equity Firm · United States

    Health CareWellnessHR TechCryptocurrency

    Portfolio: IRL, Affirm, Motherly, Forward and 82 more

    Verified email available

  • Eric LiuVerified

    Venture Capital, Private Equity Firm

    Health CareWellnessHR TechCryptocurrency

    Portfolio: IRL, Affirm, Motherly, Forward and 82 more

    Verified email available

  • Jonathan SilversteinVerified

    Private Equity Firm · United States

    Health CareLife ScienceInformation Technology (IT)Mobile

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Verified email available

  • Jonathan WangVerified

    Private Equity Firm · China

    Health CareLife ScienceInformation Technology (IT)Mobile

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Verified email available

  • Neil RuthvenVerified

    Venture Capital · United States

    Health CareWellnessHR TechCryptocurrency

    Portfolio: IRL, Affirm, Motherly, Forward and 82 more

    Verified email available

  • Rishi GuptaVerified

    Private Equity Firm · United States

    Health CareInvestment ManagementLife ScienceInformation Technology (IT)

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Verified email available

  • Carter Neild

    Venture Capital, Private Equity Firm, Investor · United States

    SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Contact details available

  • Chau Khuong

    Venture Capital, Private Equity Firm, Investor · United States

    SeedSeries AHealth CareLife ScienceInformation Technology (IT)Mobile

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Gennao Bio, Yisheng Biopharma and 89 more

    Contact details available

  • Scotland Stevens

    Venture Capital, Private Equity Firm, Investor · United States

    SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Contact details available

  • Anat Naschitz

    Private Equity Firm · Israel

    Health CareLife ScienceInformation Technology (IT)Mobile

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Contact details available

  • Erez Chimovits

    Private Equity Firm · Israel

    Health CareInvestment ManagementLife ScienceInformation Technology (IT)

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Contact details available

  • Trae Stephens

    Venture Capital, Private Equity Firm · United States

    Health CareWellnessHR TechCryptocurrency

    Portfolio: IRL, Affirm, Motherly, Forward and 82 more

    Contact details available

By investment stage

By location

Related industries

Most-backed portfolio companies

Frequently asked questions

How many AbCellera Biologics investors are on Angel Roster?

Angel Roster lists 16 AbCellera Biologics investors. 10 of them (63%) include a verified email address.

What types of investors are they?

The most common investor types are Private Equity Firms (14), Venture Capital Firms (11) and Founder-Investors (1). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do AbCellera Biologics investors invest in?

Among those that list a stage, the most common are Series A (6), Seed (5) and Series B (2).

Where are AbCellera Biologics investors based?

Most are based in the United States (12), Israel (2) and China (1).

Which companies have AbCellera Biologics investors backed?

The most-backed portfolio companies among them are Chemomab (11), VelosBio (10), Foamix (10), Azura Ophthalmics (10) and Kinnate Biopharma (10).

How do I contact AbCellera Biologics investors?

Create a free Angel Roster account to search and filter all 16, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.